Trials / Completed
CompletedNCT04160988
A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 703 (actual)
- Sponsor
- Acer Being Health Inc. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the clinical performance of VeriSee DR for DR screening from color fundus photography images in patients with diabetes mellitus. The sensitivity and specificity of VeriSee DR's automated image analysis for screening the diabetes retinopathy will be determined.
Conditions
Timeline
- Start date
- 2019-12-16
- Primary completion
- 2020-01-31
- Completion
- 2020-05-11
- First posted
- 2019-11-13
- Last updated
- 2021-01-29
- Results posted
- 2021-01-29
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04160988. Inclusion in this directory is not an endorsement.